These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11320862)

  • 1. [Cognitive impairments due to add-on therapy with topiramate].
    Huppertz HJ; Quiske A; Schulze-Bonhage A
    Nervenarzt; 2001 Apr; 72(4):275-80. PubMed ID: 11320862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
    Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
    Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Res; 2003 May; 54(2-3):171-8. PubMed ID: 12837568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy.
    Witt JA; Elger CE; Helmstaedter C
    Eur J Neurol; 2013 Jan; 20(1):130-7. PubMed ID: 22827489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive adverse events of topiramate in patients with epilepsy and intellectual disability.
    Brandt C; Lahr D; May TW
    Epilepsy Behav; 2015 Apr; 45():261-4. PubMed ID: 25843340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
    Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
    Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
    Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
    Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cognitive and behavioral effects of topiramate and valproate.
    Meador KJ; Loring DW; Hulihan JF; Kamin M; Karim R;
    Neurology; 2003 May; 60(9):1483-8. PubMed ID: 12743236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing experience with topiramate and cognition.
    Tatum WO; French JA; Faught E; Morris GL; Liporace J; Kanner A; Goff SL; Winters L; Fix A;
    Epilepsia; 2001 Sep; 42(9):1134-40. PubMed ID: 11580760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive effects of therapy with topiramate in patients with refractory partial epilepsy].
    Baeta E; Santana I; Castro G; Gonçalves S; Gonçalves T; Carmo I; Caritas AI
    Rev Neurol; 2002 Apr 16-30; 34(8):737-41. PubMed ID: 12080493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.
    Aldenkamp AP; Baker G; Mulder OG; Chadwick D; Cooper P; Doelman J; Duncan R; Gassmann-Mayer C; de Haan GJ; Hughson C; Hulsman J; Overweg J; Pledger G; Rentmeester TW; Riaz H; Wroe S
    Epilepsia; 2000 Sep; 41(9):1167-78. PubMed ID: 10999556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of the use of topiramate in patients with epilepsy.
    Sander JW
    Epilepsia; 1997; 38 Suppl 1():S56-8. PubMed ID: 9092962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar cognitive affective syndrome associated with topiramate.
    Baillieux H; Verslegers W; Paquier P; De Deyn PP; Mariën P
    Clin Neurol Neurosurg; 2008 May; 110(5):496-9. PubMed ID: 18304728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
    Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
    Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in patients with learning disability and refractory epilepsy.
    Kelly K; Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2002 Apr; 43(4):399-402. PubMed ID: 11952770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of topiramate in patients with epilepsy and intellectual deficits].
    Huber B
    Nervenarzt; 2002 Jun; 73(6):525-32. PubMed ID: 12242999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.